Related references
Note: Only part of the references are listed.Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models
Mei-Juan Tu et al.
CANCER LETTERS (2019)
Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity
Joseph L. Jilek et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
An Insight into the Roles of MicroRNAs and Exosomes in Sarcoma
Isaku Kohama et al.
CANCERS (2019)
Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis
Jieni Xu et al.
BIOMATERIALS (2019)
Risk stratification by somatic mutation burden in Ewing sarcoma
Kevin X. Liu et al.
CANCER (2019)
RNA therapy: Are we using the right molecules?
Ai-Ming Yu et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression
Xin Li et al.
ACTA PHARMACEUTICA SINICA B (2019)
Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs
Hannah Petrek et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins
Paradesi Naidu Gollavilli et al.
CANCER RESEARCH (2018)
Advances in sarcoma gene mutations and therapeutic targets
Peng Gao et al.
CANCER TREATMENT REVIEWS (2018)
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
Pui Yan Ho et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Ewing sarcoma
Thomas G. P. Gruenewald et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
Muhammad S. Beg et al.
INVESTIGATIONAL NEW DRUGS (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p
Yinting Chen et al.
BIOCHEMICAL PHARMACOLOGY (2017)
microRNAs as cancer therapeutics: A step closer to clinical application
Tina Catela Ivkovic et al.
CANCER LETTERS (2017)
MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation
Linjuan Zeng et al.
BIOCHEMICAL PHARMACOLOGY (2017)
MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU
Yin Peng et al.
CANCER LETTERS (2017)
Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
Sara Cuylen et al.
NATURE (2016)
Bioengineering of noncoding RNAs for research agents and therapeutics
Pui Yan Ho et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2016)
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest
Yong Zhao et al.
SCIENTIFIC REPORTS (2016)
MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy
Ai-Ming Yu et al.
DRUG METABOLISM AND DISPOSITION (2016)
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
Yong Zhao et al.
BIOCHEMICAL PHARMACOLOGY (2015)
microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment
Igor Koturbash et al.
BIOMARKERS IN MEDICINE (2015)
Targeted therapies for advanced Ewing sarcoma family of tumors
Yunyun Jiang et al.
CANCER TREATMENT REVIEWS (2015)
RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 status
Juergen Sonnemann et al.
EUROPEAN JOURNAL OF CANCER (2015)
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Nathalie Gaspar et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
Thomas G. P. Gruenewald et al.
NATURE GENETICS (2015)
A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications
Qiu-Xia Chen et al.
NUCLEIC ACIDS RESEARCH (2015)
MicroRNA expression and its clinical implications in Ewing's sarcoma
Zheng Li et al.
CELL PROLIFERATION (2015)
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression
M. T. Marino et al.
ANNALS OF ONCOLOGY (2014)
Therapy resistance mechanisms in Ewing's sarcoma family tumors
Atif A. Ahmed et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway
J. Li et al.
CELL PROLIFERATION (2014)
The p53/miR-34 axis in development and disease
Matjaz Rokavec et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
Mir-34: A New Weapon Against Cancer?
Gabriella Misso et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
Pengcheng Bu et al.
CELL STEM CELL (2013)
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor
G-A Franzetti et al.
ONCOGENE (2013)
MicroRNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation
Xianghui Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Caspase Functions in Cell Death and Disease
David R. McIlwain et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
Fumihiko Nakatani et al.
JOURNAL OF PATHOLOGY (2012)
Common Musculoskeletal Tumors of Childhood and Adolescence
Carola A. S. Arndt et al.
MAYO CLINIC PROCEEDINGS (2012)
Posttranscriptional Upregulation by MicroRNAs
Shobha Vasudevan
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
MicroRNAs in the p53 network: micromanagement of tumour suppression
Heiko Hermeking
NATURE REVIEWS CANCER (2012)
Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis
Igor Koturbash et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma
J. Ban et al.
ONCOGENE (2011)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
miR-194 Is a Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice
Zhipeng Meng et al.
HEPATOLOGY (2010)
Targeting microRNAs in cancer: rationale, strategies and challenges
Ramiro Garzon et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
Na Li et al.
CANCER LETTERS (2009)
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest
Fang Sun et al.
FEBS LETTERS (2008)
miR-34a repression of SIRT1 regulates apoptosis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Share Paper
